Research and Policy CSR News

Preventing the Next Pandemic: mRNA Vaccines and siRNA oligo Therapies

by Jake Adams, Project Manager at CRB
Article

Investing in promising new pharmaceutical platforms like oligonucleotide therapies could reduce the gap between first detection and total eradication in future pandemics.

The Road to a Vaccine, Ep. 5: How Nurses Are Battling the COVID-19 Pandemic

Multimedia with summary

This new eight-episode educational video series will examine the latest efforts to respond to the COVID-19 pandemic and break down the complex process of developing a vaccine.

Each week our host Lisa Ling will talk to leading scientists and researchers, healthcare workers on the front lines and public health experts around the world working collaboratively to help bring an end to the deadly pandemic.

Physically Distant, Yet Socially Close: Coping With COVID-19

by Husseini Manji, M.D., F.R.C.P.C., Global Therapeutic Head, Neuroscience at The Janssen Pharmaceutical Companies of Johnson & Johnson
Blog

I hope that everyone is staying safe and healthy as we strive to adapt to these challenging circumstances. The COVID-19 pandemic is placing a heavy burden on all of us in many ways -- including our mental health.

It is absolutely normal to feel fear, anxiety and stress related to COVID-19. In these times of uncertainty, we feel powerless. We fear for our health and that of our loved ones. For many of us, these are times of financial hardships. We are struggling to balance the demands of work and the needs of our families.

The Road to a Vaccine, Ep. 4: What Doctors on the Front Lines of COVID-19 Are Now Saying About the Virus

Multimedia with summary

This new eight-episode educational video series will examine the latest efforts to respond to the COVID-19 pandemic and break down the complex process of developing a vaccine.

Each week our host Lisa Ling will talk to leading scientists and researchers, healthcare workers on the front lines and public health experts around the world working collaboratively to help bring an end to the deadly pandemic.

She's a Scientist With One of the World's Most Important Jobs: Creating a Potential COVID-19 Vaccine

By Hanneke Schuitemaker, Ph.D., as told to Liz Ozaist, Global Content Lab Editor-in-Chief, Johnson & Johnson
Blog

She has spent her career investigating some of the world's most pervasive infectious diseases—HIV and Ebola, just to name a couple—and now Hanneke Schuitemaker, Ph.D., is fighting a virus that could very well define her career.

On #GivingTuesdayNow, American Express is Expanding Its Global Support in the Fight Against COVID-19

Press Release

NEW YORK, May 5, 2020 /3BL Media/ - On #GivingTuesdayNow, we’re proud to recognize and support the heroic efforts of organizations, essential workers and others who are putting in countless hours to care for and provide relief to communities impacted by the COVID-19 pandemic.

At the start of this crisis, American Express mobilized quickly to back nonprofits leading the charge to provide protective equipment to frontline healthcare workers, research and develop vaccines and treatments, and feed communities impacted by COVID-19. 

“I Really Felt Like I Had a Duty to Come Back.”

Chief Medical Officer at Johnson & Johnson recently returned to a Brooklyn ER to work on the frontlines of the COVID-19 crisis.
Multimedia with summary

“I really felt like I had a duty to come back.”— Dr. Ed Kuffner, Chief Medical Officer, Consumer Health, Johnson & Johnson, who recently returned to the emergency room at Coney Island Hospital in Brooklyn, New York to work on the frontlines of the COVID-19 crisis. Dr. Kuffner’s inspiring act was made possible as part of the J&J COVID-19 Medical Personnel Leave Policy, which allows employees to donate their time and expertise on the frontlines.

What the Crisis Has Shown Asset Managers: Industry Leaders Speak Out

by Maha Khan Phillips
Article

The Covid 19 crisis has fundamentally changed things, not least for the asset management industry. Whether it is about focusing on their social purpose, highlighting the importance of staying calm, emphasising leadership, arguing about the need for active management, the development of a systems framework for investing, or stressing the need for sustainability and other key factors, senior leaders tell Professional Investor what the crisis has highlighted for them. 

The Road to a Vaccine, Ep. 3: Why is COVID-19 Hitting Minority Communities So Hard?

Multimedia with summary

This new eight-episode educational video series will examine the latest efforts to respond to the COVID-19 pandemic and break down the complex process of developing a vaccine.

Each week our host Lisa Ling will talk to leading scientists and researchers, healthcare workers on the front lines and public health experts around the world working collaboratively to help bring an end to the deadly pandemic.

Pages

Subscribe to Research and Policy